The results indicate that the mRNA expression levels of CIRBP and INPP5K are significantly downregulated and associated with the clinical outcomes of patients with cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), uterine corpus endometrial carcinoma (UCEC) and ovarian serous cystadenocarcinoma (OV). The gene discussed is CIRBP; the disease is cervical squamous cell carcinoma.